Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents

Detalles Bibliográficos
Autores principales: Elmeliegy, Mohamed, Udata, Chandrasekhar, Liao, Ken, Yin, Donghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113299/
https://www.ncbi.nlm.nih.gov/pubmed/33651328
http://dx.doi.org/10.1007/s40262-021-00987-2
_version_ 1783690831857713152
author Elmeliegy, Mohamed
Udata, Chandrasekhar
Liao, Ken
Yin, Donghua
author_facet Elmeliegy, Mohamed
Udata, Chandrasekhar
Liao, Ken
Yin, Donghua
author_sort Elmeliegy, Mohamed
collection PubMed
description
format Online
Article
Text
id pubmed-8113299
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-81132992021-05-13 Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents Elmeliegy, Mohamed Udata, Chandrasekhar Liao, Ken Yin, Donghua Clin Pharmacokinet Editorial Springer International Publishing 2021-03-02 2021 /pmc/articles/PMC8113299/ /pubmed/33651328 http://dx.doi.org/10.1007/s40262-021-00987-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Editorial
Elmeliegy, Mohamed
Udata, Chandrasekhar
Liao, Ken
Yin, Donghua
Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents
title Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents
title_full Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents
title_fullStr Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents
title_full_unstemmed Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents
title_short Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents
title_sort considerations on the calculation of the human equivalent dose from toxicology studies for biologic anticancer agents
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113299/
https://www.ncbi.nlm.nih.gov/pubmed/33651328
http://dx.doi.org/10.1007/s40262-021-00987-2
work_keys_str_mv AT elmeliegymohamed considerationsonthecalculationofthehumanequivalentdosefromtoxicologystudiesforbiologicanticanceragents
AT udatachandrasekhar considerationsonthecalculationofthehumanequivalentdosefromtoxicologystudiesforbiologicanticanceragents
AT liaoken considerationsonthecalculationofthehumanequivalentdosefromtoxicologystudiesforbiologicanticanceragents
AT yindonghua considerationsonthecalculationofthehumanequivalentdosefromtoxicologystudiesforbiologicanticanceragents

Ejemplares similares